As of 2024-12-15, the EV/EBITDA ratio of HOOKIPA Pharma Inc (HOOK) is 1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HOOK's latest enterprise value is -34.08 mil USD. HOOK's TTM EBITDA according to its financial statements is -29.14 mil USD. Dividing these 2 quantities gives us the above HOOK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.1x | 13.8x |
| Forward P/E multiples | 13.4x - 15.3x | 15.0x |
| Fair Price | (27.39) - (31.45) | (29.86) |
| Upside | -1386.0% - -1576.7% | -1501.8% |
| Date | EV/EBITDA |
| 2024-12-10 | 1.05 |
| 2024-12-09 | 1.00 |
| 2024-12-06 | 1.01 |
| 2024-12-05 | 1.04 |
| 2024-12-04 | 1.03 |
| 2024-12-03 | 1.00 |
| 2024-12-02 | 0.98 |
| 2024-11-29 | 1.01 |
| 2024-11-27 | 1.03 |
| 2024-11-26 | 1.09 |
| 2024-11-25 | 1.11 |
| 2024-11-22 | 1.16 |
| 2024-11-21 | 1.10 |
| 2024-11-20 | 0.93 |
| 2024-11-19 | 0.90 |
| 2024-11-18 | 0.89 |
| 2024-11-15 | 0.81 |
| 2024-11-14 | 0.75 |
| 2024-11-13 | 0.64 |
| 2024-11-12 | 0.57 |
| 2024-11-11 | 0.52 |
| 2024-11-08 | 0.50 |
| 2024-11-07 | 0.52 |
| 2024-11-06 | 0.46 |
| 2024-11-05 | 0.48 |
| 2024-11-04 | 0.50 |
| 2024-11-01 | 0.46 |
| 2024-10-31 | 0.48 |
| 2024-10-30 | 0.45 |
| 2024-10-29 | 0.51 |
| 2024-10-28 | 0.47 |
| 2024-10-25 | 0.49 |
| 2024-10-24 | 0.43 |
| 2024-10-23 | 0.46 |
| 2024-10-22 | 0.40 |
| 2024-10-21 | 0.40 |
| 2024-10-18 | 0.35 |
| 2024-10-17 | 0.33 |
| 2024-10-16 | 0.44 |
| 2024-10-15 | 0.54 |
| 2024-10-14 | 0.52 |
| 2024-10-11 | 0.52 |
| 2024-10-10 | 0.44 |
| 2024-10-09 | 0.47 |
| 2024-10-08 | 0.43 |
| 2024-10-07 | 0.39 |
| 2024-10-04 | 0.38 |
| 2024-10-03 | 0.36 |
| 2024-10-02 | 0.37 |
| 2024-10-01 | 0.37 |